FDA commish: First Amendment DTC defense airtight

Share this article:
FDA commissioner Andrew von Eschenbach issued a staunch First Amendment defense of DTC advertising at last week’s Center for Medicine in the Public Interest conference in Washington, DC. Asked his view on the controversy over DTC and the prospects of legislative tinkering with advertising regulation, von Eschenbach said: “As with any particular entity, whether an organization or individual, there is a right to free speech and an ability under the Constitution to free expression. We need to make sure the content is factual and accurate. FDA has role in making sure the public is continuing to get correct information.”
Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.